Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Operating Leases: 2020-2024

Historic Operating Leases for Lifecore Biomedical (LFCR) over the last 5 years, with May 2024 value amounting to $1.7 million.

  • Lifecore Biomedical's Operating Leases rose 6.17% to $5.4 million in Q1 2025 from the same period last year, while for Feb 2025 it was $5.4 million, marking a year-over-year increase of 6.17%. This contributed to the annual value of $1.7 million for FY2024, which is 82.19% down from last year.
  • According to the latest figures from FY2024, Lifecore Biomedical's Operating Leases is $1.7 million, which was down 82.19% from $9.7 million recorded in FY2023.
  • In the past 5 years, Lifecore Biomedical's Operating Leases ranged from a high of $26.4 million in FY2020 and a low of $1.7 million during FY2024.
  • In the last 3 years, Lifecore Biomedical's Operating Leases had a median value of $7.7 million in 2022 and averaged $6.4 million.
  • As far as peak fluctuations go, Lifecore Biomedical's Operating Leases rose by 26.78% in 2023, and later plummeted by 82.19% in 2024.
  • Over the past 5 years, Lifecore Biomedical's Operating Leases (Yearly) stood at $26.4 million in 2020, then plummeted by 34.13% to $17.4 million in 2021, then slumped by 55.93% to $7.7 million in 2022, then climbed by 26.78% to $9.7 million in 2023, then plummeted by 82.19% to $1.7 million in 2024.